Terms: = Pancreatic cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Treatment
25 results:
1. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
2. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
3. Initiating treatment with Low Fluorouracil Dose and Titrating According to Blood Levels in Patients Treated with a 46-Hour Continuous Infusion.
Khatib AW; Selub SM; Uryvaey A; Baranseh J; Shai A
Chemotherapy; 2023; 68(2):95-101. PubMed ID: 36273438
[TBL] [Abstract] [Full Text] [Related]
4. Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation on quality of life and progression-free survival in patients with pancreatic cancer: IREC clinical study.
Rudno-Rudzińska J; Kielan W; Guziński M; Kulbacka J
Adv Clin Exp Med; 2021 Jul; 30(7):765-770. PubMed ID: 34313408
[TBL] [Abstract] [Full Text] [Related]
5. [Preoperative diagnostics in periampullary adenocarcinomas].
Wellner UF; Bolm L; Vladimirov M; Keck T
Chirurg; 2021 Sep; 92(9):771-775. PubMed ID: 34264368
[TBL] [Abstract] [Full Text] [Related]
6. Investigation of Nano-Bio Interactions within a pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in cancer treatment.
Alhussan A; Bromma K; Bozdoğan EPD; Metcalfe A; Karasinska J; Beckham W; Alexander AS; Renouf DJ; Schaeffer DF; Chithrani DB
Curr Oncol; 2021 May; 28(3):1962-1979. PubMed ID: 34073974
[TBL] [Abstract] [Full Text] [Related]
7. Detection of risk factors related to administration suspension and severe neutropenia in gemcitabine and nab-paclitaxel treatment.
Saito Y; Takekuma Y; Kobayashi M; Komatsu Y; Sugawara M
Support Care Cancer; 2021 Jun; 29(6):3277-3285. PubMed ID: 33104920
[TBL] [Abstract] [Full Text] [Related]
8. Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.
Laquente B; Macarulla T; Bugés C; Martín M; García C; Pericay C; Merino S; Visa L; Martín T; Pedraza M; Carnero B; Guardeño R; Verdaguer H; Mut A; Vilanova D; García A
BMC Palliat Care; 2020 Jul; 19(1):103. PubMed ID: 32650765
[TBL] [Abstract] [Full Text] [Related]
9. A Comprehensive Review of the Celiac Plexus Block for the Management of Chronic Abdominal Pain.
Urits I; Jones MR; Orhurhu V; Peck J; Corrigan D; Hubble A; Andrews M; Feng R; Manchikanti L; Kaye AD; Kaye RJ; Viswanath O
Curr Pain Headache Rep; 2020 Jun; 24(8):42. PubMed ID: 32529305
[TBL] [Abstract] [Full Text] [Related]
10. pancreatic cancer and Cachexia-Metabolic Mechanisms and Novel Insights.
Poulia KA; Sarantis P; Antoniadou D; Koustas E; Papadimitropoulou A; Papavassiliou AG; Karamouzis MV
Nutrients; 2020 May; 12(6):. PubMed ID: 32466362
[TBL] [Abstract] [Full Text] [Related]
11. Diagnosis and treatment of pancreatoblastoma in children: a retrospective study in a single pediatric center.
Huang Y; Yang W; Hu J; Zhu Z; Qin H; Han W; Wang H
Pediatr Surg Int; 2019 Nov; 35(11):1231-1238. PubMed ID: 31338582
[TBL] [Abstract] [Full Text] [Related]
12. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma.
Pankova D; Jiang Y; Chatzifrangkeskou M; Vendrell I; Buzzelli J; Ryan A; Brown C; O'Neill E
EMBO J; 2019 Jul; 38(13):e100532. PubMed ID: 31268606
[TBL] [Abstract] [Full Text] [Related]
13. Impact of Weight Loss During Chemotherapy in Chinese Patients with Unresectable pancreatic cancer.
Wong HCY; Lam KY; Chong CCN; Chan AWH; Chan SL
Nutr Cancer; 2019; 71(6):954-970. PubMed ID: 31058551
[No Abstract] [Full Text] [Related]
14. Thermal therapy of pancreatic tumours using endoluminal ultrasound: Parametric and patient-specific modelling.
Adams MS; Scott SJ; Salgaonkar VA; Sommer G; Diederich CJ
Int J Hyperthermia; 2016; 32(2):97-111. PubMed ID: 27097663
[TBL] [Abstract] [Full Text] [Related]
15. Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.
Pelzer U; Schwaner I; Stieler J; Adler M; Seraphin J; Dörken B; Riess H; Oettle H
Eur J Cancer; 2011 Jul; 47(11):1676-81. PubMed ID: 21565490
[TBL] [Abstract] [Full Text] [Related]
16. Well-differentiated neuroendocrine carcinoma (malignant carcinoid) of the extrahepatic biliary tract: report of two cases and literature review.
Squillaci S; Marchione R; Piccolomini M; Colombo F; Bucci F; Bruno M; Bisceglia M
APMIS; 2010 Aug; 118(8):543-56. PubMed ID: 20666735
[TBL] [Abstract] [Full Text] [Related]
17. A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors.
Amarantidis K; Xenidis N; Chelis L; Chiotis A; Tentes A; Chatzaki E; Kortsaris A; Polychronidis A; Karakitsos P; Kakolyris S
Acta Oncol; 2010; 49(2):245-51. PubMed ID: 19839918
[TBL] [Abstract] [Full Text] [Related]
18. Interventional treatment of neuroendocrine liver metastases.
Knigge U; Hansen CP; Stadil F
Surgeon; 2008 Aug; 6(4):232-9. PubMed ID: 18697366
[TBL] [Abstract] [Full Text] [Related]
19. The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.
Lam W; Leung CH; Bussom S; Cheng YC
Mol Pharmacol; 2007 Sep; 72(3):536-44. PubMed ID: 17565005
[TBL] [Abstract] [Full Text] [Related]
20. Pooled efficacy analysis from a phase I-II study of biweekly irinotecan in combination with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with metastatic pancreatic cancer.
Goel A; Grossbard ML; Malamud S; Homel P; Dietrich M; Rodriguez T; Mirzoyev T; Kozuch P
Anticancer Drugs; 2007 Mar; 18(3):263-71. PubMed ID: 17264757
[TBL] [Abstract] [Full Text] [Related]
[Next]
